Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amgen | AMGN | Nov 15, 2024 | 283.61 | -4.16 |
Amicus Therapeutics | FOLD | Nov 15, 2024 | 9.68 | -4.06 |
Amkor Technology | AMKR | Nov 15, 2024 | 25.19 | -3.19 |
AMMO | POWW | Nov 15, 2024 | 1.21 | -0.82 |
AMMO A Pref | POWWP | Nov 15, 2024 | 21.75 | +1.86 |
AMN Healthcare Services | AMN | Nov 15, 2024 | 23.70 | -0.71 |
Amneal Pharmaceuticals A | AMRX | Nov 15, 2024 | 8.47 | -5.89 |
Ampco-Pittsburgh | AP | Nov 15, 2024 | 1.66 | -6.74 |
Amphastar Pharmaceuticals | AMPH | Nov 15, 2024 | 44.61 | -1.00 |
Amphenol | APH | Nov 15, 2024 | 70.52 | -2.80 |
Amplify Energy | AMPY | Nov 15, 2024 | 6.61 | -3.08 |
Amplify Online Retail ETF | IBUY | Nov 15, 2024 | 63.90 | -1.03 |
Amplify Transformational Data Sharing ETF | BLOK | Nov 15, 2024 | 47.07 | +1.31 |
Amplitech Group | AMPG | Nov 15, 2024 | 0.88 | -2.10 |
Amplitude A | AMPL | Nov 15, 2024 | 9.59 | -4.77 |
Amprius Technologies | AMPX | Nov 15, 2024 | 2.12 | -4.93 |
AMREP | AXR | Nov 15, 2024 | 32.40 | -2.70 |
AMTD Digital ADR | HKD | Nov 15, 2024 | 2.74 | -3.18 |
AMTD Idea Group ADR | AMTD | Nov 15, 2024 | 1.13 | 0.00 |
Amtech Systems | ASYS | Nov 15, 2024 | 5.71 | 0.00 |
Amylyx Pharmaceuticals | AMLX | Nov 15, 2024 | 4.76 | -5.18 |
AN2 Therapeutics | ANTX | Nov 15, 2024 | 1.00 | 0.00 |
Analog Devices | ADI | Nov 15, 2024 | 206.35 | -2.78 |
AnaptysBio | ANAB | Nov 15, 2024 | 19.00 | -5.80 |
Anavex Life Sciences | AVXL | Nov 15, 2024 | 7.45 | -7.29 |
Andretti Acquisition II | POLE | Nov 15, 2024 | 9.98 | 0.00 |
Andretti Acquisition II Unit | POLEU | Nov 15, 2024 | 10.10 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Nov 15, 2024 | 1.59 | +4.50 |
ANEW Medical | WENA | Nov 15, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Nov 15, 2024 | 12.63 | -1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.